טוען...
Stabilizing supply of artemisinin and artemisinin-based combination therapy in an era of wide-spread scale-up
The global demand for artemisinin-based combination therapy (ACT) has grown sharply since its recommendation by the World Health Organization in 2002. However, a combination of financing and programmatic uncertainties, limited suppliers of finished products, information opacity across the different...
שמור ב:
| Main Authors: | , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2012
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3556147/ https://ncbi.nlm.nih.gov/pubmed/23198961 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2875-11-399 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|